Brought to you by:
Special invited research presentations offered at VAM
VAM traditionally includes presentations from specially invited translational researchers that are performing cutting-edge work focused on vascular disease. All are held during plenary sessions. “These presentations inform the larger VAM audience about cutting-edge translational science performed by our members and,…
Study weighs up total transfemoral and upper extremity approaches for F/BEVAR
In a prospective, non-randomized study, researchers found that a total transfemoral approach was associated with lower rates of cerebrovascular events and improved outcomes compared to an upper extremity approach during fenestrated/branched endovascular aneurysm repair (F/BEVAR). Thomas Mesnard, MD, research fellow…
Onco-vascular session set to offer ‘clinical pearls’ in ‘new’ area of vascular surgery
Randall DeMartino, MD, is Division Chair of Vascular and Endovascular Surgery at the Mayo Clinic in Rochester, Minnesota, and a co-moderator of a session dedicated to onco-vascular surgery, taking place today from 3:30–5 p.m. in National Harbor 12 A series…
Analyses offer a deeper dive into BEST-CLI trial data
As the vascular community continues to digest key insights from the BEST-CLI randomized controlled trial (RCT), attendees of Plenary Session 3 at the Vascular Annual Meeting (VAM) 2023, taking place 8:00–9:30a.m. Thursday morning in Potomac A/B, will be offered a…
VAM 2023: SVS descends on Capitol Hill
Nearly 50 SVS members took advantage of VAM’s location near Washington, D.C., visiting Capitol Hill Tuesday to discuss legislation related to vascular surgery with members of Congress and their staffs. The meetings were constituent-driven, with members talking with elected officials…
VAM 2023: Slew of special SVS section sessions set for Thursday
The SVS includes five special sections for different member groups, including physician assistants, women, young surgeons, surgeons in community practice and the Subsection on Outpatient and Office Vascular Care (SOOVC). With each section session quite popular during the 2022 VAM,…
Crawford panel focuses minds on challenges facing vascular surgery workforce numbers
Yesterday’s E. Stanley Crawford Critical Issues Forum, which looked at ways to address the pipeline of sources feeding the vascular surgery pool of talent, yielded an illuminating perspective on the looming workforce crisis currently occupying leaders in the field. Speaking…
Sex-related disparities in lower-extremity revascularization outcomes brought into focus
Women are more likely to undergo reintervention after lower extremity revascularization for peripheral arterial disease (PAD) compared to male patients with similar limb salvage and survival outcomes despite having fewer comorbidities, findings of a retrospective analysis presented during the William…
Endothelial cell granted superhero status in invited research presentation
“The endothelial cell is the superhero of the vascular system,” Kathryn L. Howe, MD, PhD, FRSCS, a vascular surgeon-scientist at the University of Toronto in Toronto, Canada, argued during an invited research presentation in Plenary Session 2 at VAM 2023.…
Significant life and limb gains for claudicants who stop smoking before lower-extremity bypass
Long-term overall survival (OS) and amputation-free survival (AFS) are outcomes that rebound in claudicants who quit smoking prior to elective surgery—and they mirror those of never smokers. But patients who don’t kick the habit have significantly worse outcomes, lighting up…